HALO
Halozyme Therapeutics, Inc.Healthcare$64.49
▲ Bullish
Mkt Cap: $7.64B|Float: 116.5M|SI: 11.8%|DTC: 7.3
Data as of market close Apr 2, 2026
IV Rank
100
IV Pctl
89%
HV 20d
27.7%
52W Range
$48-$82
ATR(14)
$1.74
Exp. Move
±5.2%
P/C Ratio
0.43
Earnings
May 5
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Above
Exp. Move Wide
Low Put/Call
HALO Key Options Data
- IV Rank
- 100%
- Total GEX
- $0.00B
- Total DEX
- $0.4M
- Max Pain
- $65.00
- Expected Move
- ±5.2%
- Put/Call OI
- 0.43
- Net Premium
- $0.1M
- Spot Price
- $64.49
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$3.33 | ±5.2% | $61.16 | $67.81 |
| 2026-05-15 | 43 | ±$6.83 | ±10.6% | $57.66 | $71.31 |
| 2026-06-18 | 77 | ±$8.35 | ±12.9% | $56.14 | $72.84 |
| 2026-09-18 | 169 | ±$12.40 | ±19.2% | $52.09 | $76.89 |
| 2026-12-18 | 260 | ±$14.35 | ±22.3% | $50.14 | $78.84 |
Explore HALO options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.